Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Documenti analoghi

• Predicting Gout Flares in People Starting Allopurinol Using the Start‐Low Go‐Slow Dose Escalation Strategy
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2024)
• Colchicine Concentrations and Relationship With Colchicine Efficacy and Adverse Events: Post Hoc Analysis of a Randomized Clinical Trial of Colchicine for Gout Flare Prophylaxis
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2025)
• Relationship Between Gout Flare States and Patient‐Reported Outcomes After Allopurinol Initiation
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2025)
• Gout Flares After Stopping Anti‐Inflammatory Prophylaxis: A Rapid Literature Review and Meta‐Analysis
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2025)
• Superiority of Low‐Dose Benzbromarone Add‐On to Low‐Dose Febuxostat Compared With Febuxostat Monotherapy in Gout With Combined‐Type Hyperuricemia
  di: Xiaomei Xue, et al.
  Pubblicazione: (2024)